Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

Lack of functional CYLD in mice leads to early aging and cancer.

Higher DHT in male baldness may protect against prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Cosmetics can contain harmful chemicals that may cause health issues.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.